000 00722nam a2200109Ia 4500
008 230817s9999 xx 000 0 und d
100 _aMichael J. Palte et al
245 0 _aImproving the Gastrointestinal Tolerability of Fumaric Acid Esters: Early Findings on Gastrointestinal Events with Diroximel Fumarate in Patients with Relapsing-Remitting Multiple Sclerosis from the Phase 3, Open-Label EVOLVE-MS-1 Study
650 _aComputer science, information & general works
856 _uhttps://new.zodml.org/sites/default/files/2023-08/improving_the_gastrointestinal_tolerability_of_fumaric_acid_esters_early_findings_on_gastrointestinal_events_with_diroximel_fumarate_in_patients_with_relapsing-remitting.pdf
942 _cEBK
999 _c38783
_d38783